Analyzing the Benefits of Using SYMPTOMS-JIT for in Vivo Exposure in Anxiety Disorders: a Randomized Controlled Trial Using a Mixed Methods Approach

What this Trial Is About

Researchers are studying anxiety disorders, including specific phobia, panic disorder, agoraphobia, and social anxiety disorder. The goal is to evaluate the effectiveness of a new smartphone-guided, sensor-based in vivo exposure therapy combined with cognitive behavioral therapy (CBT). This study compares traditional CBT with in vivo exposure to a version supported by the SYMPTOMS-JIT app, aiming to improve treatment and identify barriers to technology use in therapy. Participants will receive CBT involving psychoeducation, cognitive restructuring, emotion regulation, and coping strategies over 10 to 20 sessions. The core treatment includes repeated exposure to feared situations until distress decreases. One group receives standard in vivo exposure, while the other group uses the SYMPTOMS-JIT app to support their exposure therapy. The study includes randomized assignment to these two treatment groups. Participants will be assessed at baseline, after approximately 12 weeks of treatment, and at follow-ups after 3, 6, and 12 months. Assessments include interviews, fear and avoidance scales, and various anxiety and depression questionnaires. Researchers will monitor treatment effects, patient and therapist satisfaction, and therapy efficiency. The total participation involves initial treatment and long-term follow-up to evaluate lasting benefits and app usability.

Analyzing the Benefits of Using SYMPTOMS-JIT for in Vivo Exposure in Anxiety Disorders